Low incidence of cardiac events in an EORTC phase II study of CMF in combination with trastuzumab in women with HER-2 positive metastatic breast cancer
- Resource Type
- Abstract
- Source
- In
EJC Supplements March 2006 4(2):170-170 - Subject
- Language
- ISSN
- 1359-6349